Tag: artificial intelligence
New studies support use of Viz.ai’s solutions for detecting suspected cerebral...
Viz.ai has announced new data supporting advancements in neurology and vascular care, with two studies—both set to be presented at the Radiological Society of...
Innovation in vascular surgery: Balancing progress with patient safety
A debate at this year’s European Society for Vascular Surgery (ESVS) annual meeting (24–27 September, Kraków, Poland) centred on innovation in vascular surgery, with...
Use of AI in endoleak detection deemed “feasible” with “potentially significant”...
A recently published retrospective study has shown that a deep learning model based on non-contrast computed tomography (CT) can detect endoleak after endovascular aneurysm...
Kevin Mani
“We need to continue to build the scientific evidence base for what we do,” Kevin Mani (Uppsala, Sweden) tells Vascular News, underlining what he...
Towards a clinically applicable prediction model for aneurysm shrinkage after EVAR
Michel Reijnen and Rianne van Rijswijk (both Rijnstate Hospital, Arnhem, The Netherlands) write about a new consortium focused on sac regression after endovascular aneurysm...
Research provides “stepping stone” for future application of AI in vascular...
New research on Chat generative pre-trained transformer (GPT) technology and its Vascular Education and Self-Assessment Program (VESAP) success rate provides insight into the future...
Avicenna.AI secures European MDR certification for AI medical imaging portfolio
Avicenna.AI has received Medical Device Regulation (MDR) certification for five of its algorithms from British Standards Institution (BSI) Medical Devices—a development that means the...
Bijan Modarai
Interested in medicine from a young age, Bijan Modarai (London, UK) is now professor of vascular surgery at King’s College London and a consultant...
FDA clears AI-driven detection tool for pulmonary embolism
Medical imaging AI company Avicenna.AI has announced 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-iPE artificial intelligence (AI)-powered tool that...
Personalised, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate,...
Vascular surgeon scientist-led consortium secures €6 million in Horizon Europe funding...
The European Union Horizon Europe, with joint funding from UK Research Innovation, has awarded the NetZeroAICT Consortium €6 million in funding to develop a...
Evident Vascular exits stealth with US$35 million Series A funding to...
Evident Vascular, a medical technology startup developing an intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, recently announced...
Vascular News’ top 10 most popular stories of September 2023
Discussions on the role of aritifical intelligence in the vascular field and emerging deep venous valve technologies caught readers' attention in September.
1. Humacyte announces...
“A hugely exciting time”: Experts focus in on artificial intelligence in...
Can we trust artificial intelligence (AI)? Will AI replace physician judgement? Experts recently addressed these and other key questions amidst an expansion of AI...
RapidAI announces US$75 million growth investment led by Vista Credit Partners
RapidAI today announced US$75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the...
Artificial intelligence could enable life-saving early diagnosis and advance the treatment...
Thirona recently announced its new artificial intelligence (AI)-based algorithm for pulmonary artery-vein phenotyping, LungQ AVX. The results from multiple validation studies were presented at...
“A hugely exciting time”: Experts focus in on AI in the...
Artificial intelligence (AI) is “here to stay”. This was the closing statement from Randy Moore (Calgary, Canada), vascular surgeon and chief medical officer (CMO)...
Cydar Medical raises US$11.5m in Series A funding round, appoints new...
Cydar Medical recently announced it has successfully completed a US$11.5 million (£9.3 million) Series A funding round including a US$3.7 million (£3 million) cornerstone...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected...
Markus Steinbauer
Despite his initial intention to become a transplant surgeon, Markus Steinbauer (Krankenhaus Barmherzige Brüder, Regensburg, Germany) recalls how the rise of endovascular techniques, and...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Vascular News’ top 10 most popular stories of October 2022
Five-year outcomes from the randomised SPACE-2 trial on carotid artery stenosis, an interview with Joseph S Coselli, and a report on the "significant" increase...
Fully automated software using artificial intelligence could become a “crucial adjunct”...
A software named PRAEVAorta (Nurea), using artificial intelligence (AI), has the potential to enable a fast, reproducible, and fully automated analysis of abdominal aortic...
Cydar Medical announces appointment of chief commercial officer
Cydar Medical today announced that Alastair Harvey has been appointed in the newly created position of chief commercial officer, reporting to chief executive officer...
Vascular News’ top 10 most popular stories of July 2022
July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...
Artificial intelligence can predict risk of complications after endovascular aneurysm repair
Artificial intelligence (AI) models can be developed to predict the risk of postoperative complications after endovascular aneurysm repair (EVAR) with “high accuracy,” research presented...
Vascular News’ top 10 most popular stories of May 2022
Two-year data on the use of intravascular lithotripsy (IVL) in calcified peripheral disease treatment, an advertorial sponsored by Bentley exploring the role of bridging...
Artificial intelligence could make endovascular aortic repair outcomes more predictable
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London, UK), Tom Carrell (Cydar Medical, Barrington, UK) delivered a Podium 1st presentation titled...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
Philips integrates cloud-based AI and 3D mapping into its mobile C-arm...
Royal Philips today announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided therapy mobile C-arm system—Zenition. The...
Machine learning may help identify people at risk of thoracic aortic...
A team led by investigators at Massachusetts General Hospital (MGH) in Boston, USA, recently used deep learning to uncover insights into the genetic basis...
AI tipped to be a “gamechanger” in aortic procedures
Artificial intelligence (AI) will transform the accuracy of patient selection and endograft selection for aortic procedures. Its use will shore up computed tomography (CT)...
Viz.ai launches AI-powered modules for pulmonary embolism and aortic disease
Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
Researchers create novel solution for automatic measurement of maximum aortic diameter
Marie Lannelongue Hospital of Paris Saint-Joseph Hospital Group (Paris, France) and Incepto, a European specialist in artificial intelligence (AI) applied to the medical field,...
AI shows promise in medicine
The role of artificial intelligence (AI) has the potential to be “transformative” in medicine, including in vascular surgery. This is according to Alan Karthikesalingam,...
AI-powered remote wound assessment device as effective as bedside examination, study...
Remote wound assessment undertaken by physicians is as effective through an artificial intelligence (AI) medical device as bedside examination, a new study published in...
How artificial intelligence can be used for aneurysm follow-up
In the Aortic session at this year’s Controversies and Updates in Vascular Surgery meeting (CACVS; 23–25 January, Paris, France), Stéphan Haulon and Dominique Fabre...
The current status of new technologies and robotics in vascular surgery
In a session focused on new technologies at this year’s London Aorta meeting (10–11 October, London, UK), Celia Riga discussed the rise of robotics,...
Be an early adopter of AI to harness its benefits
Artificial intelligence (AI) is already better than humans at reading specific radiographic findings. It will impact phycisians’ jobs, but because it can currently only...
The “epidemic” of surgeon burnout and a glimpse into the future...
Ronald L Dalman (Stanford, USA), vice president of the Society for Vascular Surgery, discusses how aligning an individual surgeon’s goals with those of the...
